Pharvaris PHVS
NASDAQ PHVS
$31.41 +0.73 (+2.38%)
At close: Oct 23, 2026 · 4:00 PM EDT

Pharvaris (PHVS) Return on Invested Capital [ROIC] (2021 - 2025)

Updated

Analysis

Pharvaris (PHVS) Return on Invested Capital [ROIC] (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROIC (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 37.16%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.57%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 18.68%
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 3.56%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 34.87%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 23.26%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 14.33%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -5.97%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 13.44%
10 Pharvaris 1.86 Bn 482.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 41,178,531.01%
Dec 31, 2024 35,256,312.91%
Mar 31, 2022 -27.50%
Dec 31, 2021 -22.30%
API Access

Pharvaris Return on Invested Capital [ROIC] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=PHVS&period=max&api_key=YOUR_API_KEY